Correction to: short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study

• DA Weinstein,
• RJ Jackson,
• EA Brennan,
• M Williams,
• JE Davison,
• F de Boer,
• TGJ Derks,
• C Ellerton,
• B Faragher,
• J Gribben,
• P Labrune,
• KM McKittrick,
• E Murphy,
• KM Ross,
• U Steuerwald,
• C Voillot,
• AJM Woodward,
• HR Mundy

Affiliations

DA Weinstein

Glycogen Storage Disease Program, Connecticut Children’s Medical Center

RJ Jackson

Liverpool Clinical Trials Centre, University of LiverpoolUK

EA Brennan

Vitaflo International Ltd

M Williams

Glycogen Storage Disease Program, Connecticut Children’s Medical Center

JE Davison

Metabolic Medicine, Great Ormond Street Hospital

F de Boer

Division of Metabolic Diseases, Beatrix Children’s Hospital, University Medical Center Groningen

TGJ Derks

Division of Metabolic Diseases, Beatrix Children’s Hospital, University Medical Center Groningen

C Ellerton

Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery

B Faragher

Liverpool School of Tropical Medicine

J Gribben

Evelina London Childrens Hospital

P Labrune

Centre de Référence des Maladies héréditaires du Métabolisme Hépatique, APHP, Hôpitaux Universitaires Paris-Saclay, Hôpital Antoine Béclère, Paris-Saclay University

KM McKittrick

Vitaflo International Ltd

E Murphy

Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery

KM Ross

Glycogen Storage Disease Program, Connecticut Children’s Medical Center

U Steuerwald

Medical Center, National Hospital of the Faroe Islands

C Voillot

Centre de Référence des Maladies héréditaires du Métabolisme Hépatique, APHP, Hôpitaux Universitaires Paris-Saclay, Hôpital Antoine Béclère, Paris-Saclay University

AJM Woodward

Evelina London Childrens Hospital

HR Mundy

Evelina London Childrens Hospital